Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Journal of Clinical Medicine|July 9, 2020
Hepatitis C Virus Influences HIV-1 Viral Splicing in Coinfected PatientsPaula Martínez-Román, María Rosa López-Huertas, Celia Crespo-Bermejo, et al.Journal of Medical Virology|July 18, 2025
Low Specific T-Cell Immunity Against Mpox Elicited in People With HIV-1 and PrEP Users After Subcutaneous Vaccination Compared to Natural InfectionOlivia de la Calle-Jiménez, Guiomar Casado-Fernández, Inés Armenteros-Yeguas, et al.Journal of Clinical Medicine|December 30, 2020
Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free RemissionLorena Vigón, Alejandro Luna, Miguel Galán, et al.Journal of Clinical Medicine|July 9, 2022
Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous ClearancePaula Martínez-Román, Celia Crespo-Bermejo, Daniel Valle-Millares, et al.Scientific Reports|April 5, 2019
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional studyMaria Rosa López-Huertas, Claudia Palladino, Marta Garrido-Arquero, et al.Frontiers in Immunology|December 22, 2025
Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancerClara Sánchez-Menéndez, Jaime Rodríguez-Pérez, Daniel Fuertes, et al.Frontiers in Immunology|April 22, 2026
Correction: Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancerClara Sánchez-Menéndez, Jaime Rodríguez-Pérez, Daniel Fuertes, et al.Iscience|September 25, 2024
Characterization model of the post COVID-19 condition based on immunological, biochemical, and cytokine markersBárbara Oliván-Blázquez, Marta Bona-Otal, Fátima Méndez-López, et al.Biochemical Pharmacology|June 29, 2021
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapyLorena Vigón, Paula Martínez-Román, Sara Rodríguez-Mora, et al.Cancers|November 26, 2022
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine BoosterMontserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, et al.Pageof 8